Your browser doesn't support javascript.
loading
Current state of Alzheimer's fluid biomarkers.
Molinuevo, José Luis; Ayton, Scott; Batrla, Richard; Bednar, Martin M; Bittner, Tobias; Cummings, Jeffrey; Fagan, Anne M; Hampel, Harald; Mielke, Michelle M; Mikulskis, Alvydas; O'Bryant, Sid; Scheltens, Philip; Sevigny, Jeffrey; Shaw, Leslie M; Soares, Holly D; Tong, Gary; Trojanowski, John Q; Zetterberg, Henrik; Blennow, Kaj.
Afiliação
  • Molinuevo JL; BarcelonaBeta Brain Research Center, Fundació Pasqual Maragall, Universitat Pompeu Fabra, Barcelona, Spain.
  • Ayton S; Unidad de Alzheimer y otros trastornos cognitivos, Hospital Clinic-IDIBAPS, Barcelona, Spain.
  • Batrla R; Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.
  • Bednar MM; Roche Centralised and Point of Care Solutions, Roche Diagnostics International, Rotkreuz, Switzerland.
  • Bittner T; Neuroscience Therapeutic Area Unit, Takeda Development Centre Americas Ltd, Cambridge, MA, USA.
  • Cummings J; Genentech, A Member of the Roche Group, Basel, Switzerland.
  • Fagan AM; Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA.
  • Hampel H; Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
  • Mielke MM; AXA Research Fund and Sorbonne University Chair, Paris, France.
  • Mikulskis A; Sorbonne University, GRC No 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • O'Bryant S; Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France.
  • Scheltens P; Department of Neurology, Institute of Memory and Alzheimer's Disease (IM2A), Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
  • Sevigny J; Departments of Epidemiology and Neurology, Mayo Clinic, Rochester, MN, USA.
  • Shaw LM; Biomarkers, Biogen, Cambridge, MA, USA.
  • Soares HD; Department of Pharmacology and Neuroscience; Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, USA.
  • Tong G; Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands.
  • Trojanowski JQ; Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.
  • Zetterberg H; Department of Pathology and Laboratory Medicine, and Center for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, PA, USA.
  • Blennow K; Clinical Development Neurology, AbbVie, North Chicago, IL, USA.
Acta Neuropathol ; 136(6): 821-853, 2018 12.
Article em En | MEDLINE | ID: mdl-30488277
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Doença de Alzheimer Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Doença de Alzheimer Idioma: En Ano de publicação: 2018 Tipo de documento: Article